Table 4.
Number of days of disposable income to afford anti-malarials
|
Outlet type |
|
---|---|---|
Private | Not-for-profit | |
Anti-malarials |
|
|
AL |
0.50 |
0.40 |
Other forms of ACT |
3.20 |
1.34 |
Quinine | 0.54 | 0.40 |
AL, artemether-lumefantrine; ACT, artemisinin-based combination therapy. Affordability was expressed as median price (numerator) against lowest daily disposable income level (at KES 150, USD 1.875 = denominator).